Mycobacterium tuberculosis complex in atherosclerosis

Acta Medica Okayama

Volumn 59, Issue 6, 2005, Pages 247-251

  Rota, Simin ^a   Rota, Seyyal ^b  

^a PAMUKKALE UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Atherosclerosis; BCG; Heat shock protein; M. tuberculosis; Phospholipid

Indexed keywords

BACTERIAL PROTEIN; BACTERIUM ANTIBODY; BCG VACCINE; CHAPERONIN; HEAT SHOCK PROTEIN 65, MYCOBACTERIUM; HEAT-SHOCK PROTEIN 65, MYCOBACTERIUM; PHOSPHOLIPID;

ATHEROSCLEROSIS; BLOOD; CELL WALL; CHEMISTRY; HUMAN; IMMUNOLOGY; MYCOBACTERIUM TUBERCULOSIS; PATHOGENICITY; REVIEW;

ANTIBODIES, BACTERIAL; ATHEROSCLEROSIS; BACTERIAL PROTEINS; BCG VACCINE; CELL WALL; CHAPERONINS; HUMANS; MYCOBACTERIUM TUBERCULOSIS; PHOSPHOLIPIDS;

ANIMALIA; CHLAMYDOPHILA PNEUMONIAE; CYTOMEGALOVIRUS; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS COMPLEX;

EID: 31344480342     PISSN: 0386300X     EISSN: 0386300X     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. George J, Shoenfeld Y, Afek A, Gilburd B, Keren P, Shaish A, Kopolovic J, Wick G and Harats D: Enhanced fatty streak formation in C57BL/6J mice by immunization with heat shock protein-65. Arterioscler Thromb Vasc Biol (1999) 19: 505-510.
2. Zügel U and Kaufmann SH: Activation of CD8 T cells with specificity for Mycobacterial heat shock protein 60 in Mycobacterium bovis bacillus Calmette-Guerin-vaccinated mice. Infect Immun (1997) 65: 3947-3950.
3. Fong IW: Emerging relations between infectious diseases and coronary artery disease and atherosclerosis. CMAJ (2000) 163: 49-56.
4. Shah PK: Link between infection and atherosclerosis. Who are the culprits: viruses, bacteria, both, or neither? Circulation (2001) 103: 5-6.
5. Kiechl S, Egger G, Mayr M, Wiedermann CJ, Bonora E, Oberhollenzer F, Muggeo M, Xu Q, Wick G, Poewe W and Willeit J: Chronic infections and the risk of carotid atherosclerosis prospective results from a large population study. Circulation (2001) 103: 1064-1070.
6. Roivainen M, Viik-Kajander M, Palosuo T, Toivainen P, Leinonen M, Saikku P, Tekanen L, Manninen V, Hovi T and Mantarri M: Infections, inflammation, and the risk of coronary heart disease. Circulation (2000) 101: 252-257.
7. Laurila AL, Bloigu A, Nayha S, Hassi J, Leinonen M and Saikku P: Chlamydia pneumoniae antibodies associated with altered serum lipid profile. Int J Circumpolar Health (1998) 57 Suppl I: 329-332.
8. Zhou YF, Shou M, Guetta E, Guzman R, Unger EF, Yu ZX, Zhang J, Finkel T and Epstein SE: Cytomegalovirus infection of rats increases the neointimal response to vascular injury without consistent evidence of direct infection of the vascular wall. Circulation (1999) 100: 1569-1575.
9. George J, Shoenfeld Y, Gilburd B, Afek A, Shaish A and Harats D: Requisite role for interleukin-4 in the acceleration of fatty streaks induced by heat shock protein 65 or Mycobacterium tuberculosis. Circ Res (2000) 86: 1203-1210.
10. Stollberger C and Finsterer J: Role of Infectious and immune factors in coronary and cerebrovascular arteriosclerosis. Clin Diagn Lab Immunol (2002) 9: 207-215.
11. Shoenfeld Y, Sherer Y and Harats D: Atherosclerosis as an infectious, inflammatory and autoimmune disease. Trends Immunol (2001) 22: 293-295.
12. Chmiela M, Kowalewicz-Kulbat M, Miszczak A, Wisniewska M, Rechcinski T, Kolodziej K, Kasprzak J, Wadstrom T and Rudnicka W: A link between Helicobacter pylori and/or Chlamydia spp. infections and atherosclerosis. FEMS Immun Med Microbiol (2003) 36: 187-192.
13. Muhlestein JB, Horne BD, Carlquist JF, Madsen TE, Bair TL, Pearson RR and Anderson JL: Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease. Circulation (2000) 102: 1917-1923.
14. Miyashita N, Toyota E, Sawayama T, Matsumoto A, Mikami Y, Kawai N, Takada K, Niki Y and Matsushima T: Association of chronic infection of Chlamydia pneumoniae and coronary heart disease in the Japanese. Intern Med (1998) 37: 913-916.
15. Mayr M, Kiechl S, Willeit J, Wick G and Xu Q: Infections, immunity, and atherosclerosis: associations of antibodies to Chylamydia pneumoniae, Helicobacter pylori and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation (2000) 102: 833-839.
16. Hoffmeister A, Rothenbacher D, Bode G, Persson K, Marz W, Nauck MA, Brenner H, Hombach V and Koenig W: Current infection with Helicobacter pylori, but not seropositivity to Chylamydia pneumoniae or cytomegalovirus, is associated with an atherogenic modified lipid profile. Arterioscler Thromb Vasc Biol (2001) 21: 427-432.
17. Folsom AR, Nieto FJ, Sorlie P, Chambless LE and Graham DY: Helicobacter pylori seropositivity and coronary heart disease incidence. Atherosclerosis Risk In Communities (ARIC) study investigators. Circulation (1998) 98: 845-850.
18. Gupta S and Camm AJ. Is there an infective aetiology to atherosclerosis? Drugs Aging (1998) 13: 1-7.
19. Wells BJ, Mainous AG 3rd and Dickerson LM. Antibiotics for the secondary prevention of ischemic heart disease. A meta-analysis of randomized controlled trials. Arch Interm Med (2004) 164: 2156-2161.
20. Maass M, Krause E, Engel PM and Kruger S: Endovascular presence of Chlamydia pneumoniae in patients with hemodynamically effective carotid artery stenosis. Angiology (1997) 48: 699-706.
21. Maass M, Bartels C, Kruger S, Krause E, Engel PM and Dalhoff K: Endovascular presence of Chlamydia pneumoniae DNA is a generalized phenomenon in atherosclerotic vascular disease. Atherosclerosis (1998) 140: S25-30.
22. Horvath R, Cerny J, Benedik J Jr, Hokl J, Jelinkova I and Benedik J: The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis. J Clin Virol (2000) 16: 17-24.
23. Qavi HB, Melnick JL, Adam E and Debakey ME: Frequency of coexistence of cytomegalovirus and Chlamydia pneumoniae in atherosclerotic plaques. Cent Eur J Public Health (2000) 8: 71-73.
24. Jackson LA, Campbell LA, Kuo CC, Rodriguez DI, Lee A and Grayston JT: Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis (1997) 176: 292-295.
25. Paterson DL, Hall J, Rasmussen SJ and Timms P: Failure to detect Chlamydia pneumoniae in atherosclerotic plaques of Australian patients. Pathology (1998) 30: 169-172.
26. Degre M: Has cytomegalovirus infection any role in the development of atherosclerosis? Clin Microbiol Infect (2002) 8: 191-195.
27. Andreasen JJ, Farholt S and Jensen JS: Failure to detect Chlamydia pneumoniae in calcific and degenerative arteriosclerotic aortic valves excised during open heart surgery. APMIS (1998) 106: 717-720.
28. Wick G, Perschinka H and Xu Q: Autoimmunity and atherosclerosis. Am Heart J (1999) 138: S444-449.
29. Xu Q, Kiechl S, Mayr M, Metzler B, Egger G, Oberhollenzer F, Willeit J and Wick G: Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Clinical significance determined in a follow-up study. Circulation (1999) 100: 1169-1174.
30. Mayr M, Metzler B, Kiechl S, Willeit J, Schett G, Xu Q and Wick G: Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat shock proteins as a possible link between infection and atherosclerosis. Circulation (1999) 99: 1560-1566.
31. Zhu J, Quyyumi AA, Rott D, Csako G, Wu H, Halcox J and Epstein SE: Antibodies to human heat-shock protein 60 are associated with the presence and severity of coronary artery disease: evidence for an autoimmune component of atherogenesis. Circulation (2001) 103: 1071-1075.
32. Mukherjee M, De Benedicts C, Jewitt D and Kakkar VV: Association of antibodies to heat-shock protein-65 with percutaneous transluminal coronary angioplasty and subsequent restenosis. Thromb Haemost (1996) 75: 258-260.
33. George J, Greenberg S, Barshack I, Goldberg I, Keren G and Roth A: Immunity to heat shock protein 65- an additional determinant in intimai thickening. Atherosclerosis (2003) 168: 33-38.
34. Lamb DJ, El-Sankary W and Ferns GA: Molecular mimicry in atherosclerosis: a role for heat shock proteins in immunization. Atherosclerosis (2003) 167: 177-185.
35. Lamb DJ and Ferns GA: The magnitude of the immune response to heat shock protein-65 following BCG immunisation is associated with the extent of experimental atherosclerosis. Atherosclerosis (2002) 165: 231-240.
36. Perschinka H, Mayr M, Millonig G, Mayerl C, van der Zee R, Morrison SG, Morrison RP, Xu Q and Wick G: Cross-Reactive B-Cell Epitopes of Microbial and Human Heat Shock Protein 60/65 in Atherosclerosis. Arterioscler Thromb Vasc Biol (2003) 23: 1060-1065.
37. Rota S, McWilliam NA, Baglin TP and Byrne CD: Atherogenic lipoproteins support assembly of the prothrombinase complex and thrombin generation: modulation by oxidation and vitamin E. Blood (1998) 9: 508-515.
38. Pryzdial EL and Wright JF: Prothrombinase assembly on an enveloped virus: evidence that the Cytomegalovirus surface contains procoagulant phospholipid. Blood (1994) 84: 3749-3757.
39. Folgueria L, Delgado R, Palenque E, Aguado JM and Noriega AR: Rapid diagnosis of Mycobacterium tuberculosis bacteriemia by PCR. J Clin Microbiol (1996) 34: 512-515.
40. David ST, Mukundan U, Brahmadathan KN and John TJ: Detecting mycobacteraemia for diagnosing tuberculosis. Indian J Med Res (2004) 119: 259-266.